Kiwi mum s heartbreak after surrogate terminates her pregnancy: I went into shock
7 May, 2021 06:25 PM
9 minutes to read
A Kiwi couple were preparing to welcome their baby via surrogate when the woman who had agreed to carry for them told them she had miscarried. Photo / Getty Images
A Kiwi couple were preparing to welcome their baby via surrogate when the woman who had agreed to carry for them told them she had miscarried. Photo / Getty Images
Other
When Jane and her husband John heard the news that their surrogate was pregnant last September, they were overjoyed. For Jane, who had a troubled first pregnancy carrying their daughter Jenny , it meant another chance at motherhood.
This fertility tech startup offers affordable, accessible treatment that’s free of gender bias
Bengaluru-based fertility tech startup Janani uses AI and computer vision to make the journey to conception easier and more affordable, and create a gender-neutral, one-stop solution for sexual and reproductive wellness.
0 claps
The
World Health Organisation (WHO) states that infertility plagues 30 million couples in India every year. Of these, nearly three million are actively seeking treatment. However, awareness about fertility issues, especially pertaining to male infertility, and knowledge about the various treatment options is highly limited.
Nilay Mehrotra, who hails from a family of healthcare professionals, was always keen on contributing to India’s healthcare ecosystem and in 2018 started researching areas where he could make a difference with an innovative healthtech offering.
INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors
Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand building
News provided by
Share this article
SARASOTA, Fla., April 26, 2021 /PRNewswire/
INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world s only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Rebecca Messina to the Company s board of directors, effective immediately.
Messina has broad international experience in leading marketing for elite brands and businesses including Uber, Beam Suntory and The Coca-Cola Company. She is currently a Senior Advisor at McKinsey & Company focused on advising internal teams and firm clients in the areas of marketing as a growth lever, including data driven marketing, brand building, and strategicall
You’ve probably heard the saying, “If at first you don’t succeed, try and try again.” Well, when it comes to in vitro fertilization (IVF, a form of assisted reproductive technology whereby doctors combine egg and sperm in a lab dish before transferring the embryo to the uterus, the saying is likely “try, try, and try some more. And maybe you’ll get the result you want.”
I might sound less-than-reassuring, but IVF can be challenging. Though it’s one of the most successful forms of assisted reproductive technology, the live birth rate from one IVF cycle is about 55.6% for people under 35, and 40.8% for folks between the ages of 35 and 37, according to the Society for Assisted Reproductive Technology (SART). The live birth rate falls to 4.1% for people over 42 years old, SART explains. And even for those who undergo in vitro fertilization treatment and become parents, it takes an average of 3.6 IVF cycles to achieve pregnancy, according to the National Institutes of Hea